Overview
Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.
Description
Aims of the study:
- Prospective evaluation of the association between preoperative interleukin-6 levels and local tumor stage in patients undergoing radical cystectomy
- Prospective assessment of interleukin-6, procalcitonin and wound drainage culture as early indicators for perioperative infectious complications after cystectomy
- Prospective evaluation of physician-assessed vs. patient-reported grading of complications after cystectomy
- Prospective comparison of infectious complications within the first 12 months after cystectomy: ileal neobladder vs. ileal conduit
- Prospective evaluation of the association between in-hospital complications after cystectomy and quality of life after three months
Eligibility
Inclusion Criteria:
- Disease which requires removal of the urinary bladder
Exclusion Criteria:
- Patient does not want to participate
